| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 02/07/1991 | WO1990015069A3 Amino acid derivative anticonvulsant |
| 02/06/1991 | EP0412012A1 Technetium 99m labelled polypeptides and their applications in imaging systems |
| 02/06/1991 | EP0411925A2 Process for cross-linking collagenous materials and resulting product |
| 02/06/1991 | EP0411751A1 Renin inhibitory peptides |
| 02/06/1991 | EP0411678A1 Method for the production of erythropoietin |
| 02/06/1991 | EP0411503A1 Process for identifying and synthesizing binding sites of interacting proteins |
| 02/06/1991 | EP0411334A1 Antiherpes pentapeptide derivatives having a substituted aspartic acid side chain |
| 02/06/1991 | EP0411333A1 Antiherpes tetrapeptide derivatives having a substituted aspartic acid side chain |
| 02/06/1991 | EP0411332A1 Antiviral peptides having a 2-oxoalkyl amino acid side chain |
| 02/06/1991 | EP0411031A1 THE HUMAN C3b/C4b RECEPTOR (CR1) |
| 02/06/1991 | EP0410989A1 Cyclic analogs of atrial natriuretic peptides |
| 02/06/1991 | CN1049016A Peptidase inhibitors |
| 02/06/1991 | CA2022692A1 Renin inhibitors |
| 02/05/1991 | WO1991001753A1 Inhibition of tumor growth by blockade of the protein c system |
| 02/05/1991 | US4990644 Sulfonium compound and acylating agent |
| 02/05/1991 | US4990597 Contacting with carrier-bound saccharide polysulfate in presence of calcium, elution |
| 02/05/1991 | US4990452 Combining mutations for stabilization of subtilisin |
| 02/04/1991 | WO1991001995A1 High gel strength and low electroendosmosis agarose |
| 02/03/1991 | CA2022270A1 Process for the labeling of proteins or polypeptides with technetium-99m, conjugate thus obtained, use as imaging agent, kit for the reconstitution of these conjugates |
| 01/31/1991 | DE4021979A1 Isolation of annexin protein(s) from cell lysate(s) |
| 01/31/1991 | DE3924257A1 New tri:alkoxy-silyl derivs. - which are of aminoacid(s), sugars, etc. useful as protected intermediates |
| 01/30/1991 | EP0410751A2 Gene encoding M-CSF and related recombinant systems thereof |
| 01/30/1991 | EP0410750A2 Use of Interleukin-4 for increasing numbers of neutrophils and for treating myeloid or monocytoid leukaemia. |
| 01/30/1991 | EP0410671A1 Acylated epidermal growth factor |
| 01/30/1991 | EP0410411A2 Novel peptidase inhibitors |
| 01/30/1991 | EP0410323A2 Immobilization of proteins and peptides on insoluble supports |
| 01/30/1991 | EP0410280A1 Heterobifunctional compounds |
| 01/30/1991 | EP0410278A1 Renin inhibiting aminooligohydroxy-derivatives |
| 01/30/1991 | EP0410260A2 Peptidyl aminodiol renin inhibitors |
| 01/30/1991 | EP0410246A1 Erythropoietin(EPO)-peptides and antibodies against them |
| 01/30/1991 | EP0410207A2 Stabilization of highly purified proteins |
| 01/30/1991 | EP0410182A2 A new technique for rapid peptide coupling |
| 01/30/1991 | EP0409923A1 EXPRESSION OF THE i(PLASMODIUM) CIRCUMSPOROZOITE PROTEIN IN INSECT CELLS |
| 01/30/1991 | EP0409892A1 Combining mutations for stabilization of subtilisin |
| 01/30/1991 | EP0357750A4 Urethane-protected amino acid-n-carboxyanhydrides |
| 01/29/1991 | WO1991001738A1 Dithiochrome, an insulin-binding molecule with glucose metabolism-related pharmaceutical utility |
| 01/29/1991 | US4988798 Method for recovering recombinant proteins |
| 01/29/1991 | US4988625 Carbonyldiimidazole treatment of the support crosslinking to form a carbamate with polysaccharides |
| 01/29/1991 | CA2064036A1 Dithiochrome, an insulin-binding molecule with glucose metabolism-related pharmaceutical utility |
| 01/29/1991 | CA2022185A1 Separation of anti-metal chelate antibodies |
| 01/29/1991 | CA1279592C Nortriptyline conjugates to antigenic proteins and enzymes |
| 01/27/1991 | CA2021740A1 Peptidyl aminodiol renin inhibitors |
| 01/27/1991 | CA2021660A1 Peptidase inhibitors |
| 01/26/1991 | CA2021822A1 Renin-inhibiting amino oligohydroxy derivatives |
| 01/25/1991 | CA2021452A1 Stabilization of highly purified proteins |
| 01/24/1991 | WO1991000871A1 Surfactant compositions and methods |
| 01/23/1991 | EP0409814A1 Variant proteins and polypeptides possessing enhanced affinity for immobilized-metal affinity matrices |
| 01/23/1991 | EP0409607A2 Antibody to human interleukin-6 receptor |
| 01/23/1991 | EP0409053A1 Process for purifying annexins |
| 01/23/1991 | EP0409045A2 Pentapeptide antibiotics derived from dalbaheptides |
| 01/23/1991 | EP0408973A1 Antiherpes pentapeptides |
| 01/23/1991 | EP0408661A1 Methods of generating desired amino-terminal residues in proteins |
| 01/23/1991 | EP0408649A1 Bone and cartilage inductive compositions |
| 01/23/1991 | EP0408634A1 Organic synthesis employing supercritical carbon dioxide as a reaction solvent |
| 01/23/1991 | EP0408585A1 Immobilized artificial membranes |
| 01/23/1991 | EP0365654A4 Elastomeric polypeptides as vascular prosthetic materials |
| 01/23/1991 | EP0302928B1 Inorganic filtration membrane modified for protein separation |
| 01/22/1991 | US4987122 Peptide compounds and medical method of use thereof |
| 01/22/1991 | CA1279276C Polypeptides and antibiotics characteristic of papillomavirus and use for the in vitro diagnostic, the prevention and/or the control of papillomavirus infections |
| 01/19/1991 | CA2021369A1 Tumor necrosis factor (tnf) inhibitor and method for obtaining the same |
| 01/18/1991 | WO1991001331A1 Small cyclic platelet aggregation inhibitors |
| 01/18/1991 | CA2063557A1 Small cyclic platelet aggregation inhibitors |
| 01/16/1991 | EP0408371A1 Hemoregulatory peptides |
| 01/16/1991 | EP0408157A1 Acid-cleavable compound |
| 01/16/1991 | EP0408146A2 Method for the purification of therapeutically active recombinant acidic fibroblast growth factor |
| 01/16/1991 | EP0408029A1 Method of fractionating plasma protein |
| 01/16/1991 | EP0407897A1 Compounds of biopolymers effector substances bonded together by optically active aminoacidic derivatives, process for their preparation and their use |
| 01/16/1991 | EP0407813A2 Oxidative denaturation of protein analytes |
| 01/16/1991 | EP0407543A1 Mammalian gap-43 compositions and methods of use |
| 01/16/1991 | EP0407527A1 Carboxyl terminal peptide and protein sequencing |
| 01/16/1991 | EP0407451A1 General cancer-associated scm-recognition factor, preparation and method of use |
| 01/16/1991 | EP0407399A1 Immunosupression with anti-pan t-cell immunotoxin compositions |
| 01/16/1991 | EP0227833B1 Process for preparing hetero-protein |
| 01/16/1991 | CA2021147A1 Process for preparing and purifying an anticoagulant |
| 01/15/1991 | US4985544 Process for renaturing fish growth hormone |
| 01/15/1991 | US4985543 Lectins and antiretroviral drugs containing the lectins as active ingredient |
| 01/15/1991 | US4985417 Treatment of glaucoma |
| 01/15/1991 | US4985407 Renin Inhibitors, Treating Cardiovascular Disorders, Hypotensive Agents |
| 01/15/1991 | US4985406 Central nervous system disorders, dopaminergic pathways |
| 01/15/1991 | US4985362 Process of purifying tPA |
| 01/15/1991 | US4985144 Purification of protein antigens |
| 01/14/1991 | CA2020720A1 Method for the purification of therapeutically active recombinant acidic fibroblast growth factor |
| 01/12/1991 | CA2019893A1 Method of fractionating plasma protein |
| 01/11/1991 | CA2020768A1 Compounds from biopolymers and effector substances which are linked via optically active amino acid derivatives, processes for the preparation thereof and the use thereof |
| 01/10/1991 | WO1991000517A1 Method of assisting material design and apparatus therefor |
| 01/10/1991 | WO1991000344A1 Enzyme production |
| 01/10/1991 | WO1991000295A1 Novel antibodies reactive with human carcinomas |
| 01/10/1991 | WO1991000292A1 Compositions and methods for the synthesis of natriuretic protein receptor b and methods of use |
| 01/10/1991 | WO1991000289A2 Targeted liposomes and methods for liposome-protein coupling |
| 01/10/1991 | WO1991000111A1 Targetting agents |
| 01/10/1991 | CA2059131A1 Compositions and methods for the synthesis of natriuretic protein receptor b and methods of use |
| 01/09/1991 | EP0407122A1 Novel modified PF4 compositions and methods of use |
| 01/09/1991 | EP0407092A1 Lymphocyte-activating factor, method for the preparation thereof and method for the proliferation of antibody-forming lymphocytes and production of antibody using the same |
| 01/09/1991 | EP0406931A2 New analogues of all-bond retroinverted thymopentin, the method for the synthesis of the same and their employment for the preparation of pharmaceutical compositions |
| 01/09/1991 | EP0406856A2 Stabilized FGF composition and production thereof |
| 01/09/1991 | EP0406850A1 Process for obtaining purple membranes containing bacteriorhodopsin |
| 01/09/1991 | EP0406402A1 Cloning and expression of a variant gene of platelet factor 4 and compositions thereof to modulate immune responses |
| 01/09/1991 | EP0406385A1 Separation of antigens with a second antibody specific for the kappa chain of a first antibody |
| 01/09/1991 | EP0406367A1 Scavenger receptor protein and antibody thereto |
| 01/09/1991 | EP0406357A1 Functional recombinantly prepared synthetic protein polymer |